Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Notification

18 Sep 2020 09:47

RNS Number : 4313Z
Scapa Group PLC
18 September 2020
 

18 September 2020

LEI No. 213800QIPVTK5ES5UU36

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

Scapa Group plc (AIM: SCPA) today announces that on 16 September 2020, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2019 Long Term Incentive Plan ('LTIP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.

 Name / Position of PDMR

Number of Ordinary Shares over which the option is held

Oskar Zahn - Chief Financial Officer

300,172

John Petreanu - President Healthcare

254,113

Brett Pollard - MD Global Corporate Dev & Strategy

75,043

Wendy Baker - Group General Counsel and CoSec

145,798

In accordance with the rules of the LTIP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the LTIP and the legislation relating to the LTIP.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

ANNEX

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Oskar Zahn

 

2

Reason for the notification

 

a)

Position / status

Chief Financial Officer

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

300,172 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

16 September 2020

 

f)

Place of the transaction

Off Market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

John Petreanu

 

2

Reason for the notification

 

a)

Position / status

President, Healthcare

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

254,113 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brett Pollard

 

2

Reason for the notification

 

a)

Position / status

MD, Global Corp Development & Strategy

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

75,043 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Wendy Baker

 

2

Reason for the notification

 

a)

Position / status

Group General Counsel and CoSec

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

145,798 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

Off Market

 

 

 

For further information:

 

Scapa Group plc:

Wendy Baker +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander/Freddie Barnfield

(Joint Broker/Nominated Adviser)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWSWRRSUKARR
Date   Source Headline
23rd Jul 20137:00 amRNSAGM Statement
16th Jul 20134:23 pmRNSHolding(s) in Company
5th Jul 20131:07 pmRNSHolding(s) in Company
4th Jul 201310:54 amRNSAdditional Listing
1st Jul 201312:05 pmRNSDTR 5.6.1
24th Jun 20137:00 amRNSNotice of AGM
21st Jun 20132:04 pmRNSAdditional Listing
29th May 20137:00 amRNSFinal Results
17th May 20138:30 amRNSHolding(s) in Company
7th May 20132:48 pmRNSHolding(s) in Company
7th May 201311:03 amRNSResponse to Press Speculation
26th Apr 20137:00 amRNSDisposal
16th Apr 201310:24 amRNSAdditional Listing
11th Apr 20137:00 amRNSTrading Statement
22nd Mar 201311:48 amRNSAdditional Listing
21st Mar 20137:00 amRNSResponse to Press Speculation
20th Mar 20131:26 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNSStatement re Pension Deficit Funding Arrangements
28th Feb 20139:04 amRNSAdditional Listing
7th Feb 201310:28 amRNSBlocklisting Interim Review
5th Feb 201310:29 amRNSHolding(s) in Company
31st Jan 20133:19 pmRNSHolding(s) in Company
17th Jan 20139:25 amRNSAdditional Listing
16th Jan 20137:00 amRNSChange of Adviser
27th Dec 201212:13 pmRNSDirector/PDMR Shareholding
20th Dec 20127:00 amRNSDirector/PDMR Shareholding
27th Nov 20127:00 amRNSHalf Yearly Report
11th Oct 20127:00 amRNSTrading Statement
26th Sep 20124:39 pmRNSHolding(s) in Company
17th Sep 20121:54 pmRNSHolding(s) in Company
7th Aug 20129:07 amRNSBlocklisting Interim Review
24th Jul 20127:00 amRNSAGM Statement
29th Jun 20121:04 pmRNSHolding(s) in Company
29th Jun 201211:35 amRNSHolding(s) in Company
26th Jun 20129:36 amRNSNotice of AGM
30th May 201210:32 amRNSAdditional Listing
29th May 20127:00 amRNSFinal Results
17th May 20125:31 pmRNSHolding(s) in Company
17th May 20125:24 pmRNSHolding(s) in Company
2nd May 20123:39 pmRNSHolding(s) in Company
2nd May 20123:36 pmRNSHolding(s) in Company
1st May 20123:58 pmRNSAdditional Listing
30th Apr 20124:35 pmRNSHolding(s) in Company
19th Apr 201212:08 pmRNSHolding(s) in Company
13th Apr 20129:54 amRNSHolding(s) in Company
12th Apr 20127:00 amRNSPeriod end update
30th Mar 201210:55 amRNSTotal Voting Rights
29th Mar 20122:42 pmRNSHolding(s) in Company
29th Mar 20128:00 amRNSSite Visit
20th Mar 20122:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.